News
Chromalytica participated at French-Swedish Life Science Day 2016 in Paris, France.
Chromalytica participated at French-Swedish Life Science Day 2016 in Paris, France. Chromalytica was chosen together with 23 companies to participate in the … READ MORE
Chromalytica is about to start a clinical study on patients affected by COPD and lung cancer.
Chromalytica is about to start a clinical study on patients affected by COPD and lung cancer. The study is financed … READ MORE
Relationship with China gets stronger.
A delegation of representatives from Chinese business life recently visited Chromalytica at its headquarters at Medeon Science Park in Sweden. … READ MORE
Chromalytica at Zurich Stock Exchange.
On February 10, we joined 167 participants at Swiss-Scandinavian Bio-Business Seminar 2016 in Zurich. Our CEO Mr. Francesco Palmisano presented … READ MORE
November 27-30. Zhongshan Forum for Health and Development.
November 27-30. Zhongshan Forum for Health and Development Mr. Francesco Palmisano, CEO Chromalytica AB, presented at Zhongshan Forum for Health … READ MORE
November 2-4. Bio-Europe 2015.
November 2-4. Bio-Europe 2015 Mr. Francesco Palmisano, CEO Chromalytica AB, was at Bio-Europe 2015 in Munich, Germany. Mr. Palmisano had … READ MORE
International Conference on Health, Healthcare and Eco-civilisation.
September 5-6 International Conference on Health, Healthcare and Eco-civilisation. Dr. Thomas Lundeberg, CMO Chromalytica AB, was invited to the International … READ MORE
June 26, 2014
AGM Annual General Meeting was held at Chromalytica AB, Medeon Science Park in Malmoe, Sweden.
June 5 2014
Chromalytica AB presents at Skåne Innovation Week, “Diagnostics for the future” Medeon, Malmö, June 5. 2014
June 4 2014
Chromalytica AB was awarded as, without internal ranking, one of twenty out of 800 Swedish companies from the Swedish Governmental … READ MORE